Moderna spikes as Oracle’s Larry Ellison touts AI-driven mRNA vaccines
Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.
Moderna: Is Stock a Buy? Breaking Down the Latest Guidance
"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...
Moderna Shares Are Up Today: What's Going On?
Shares of Moderna are trading higher Wednesday after Oracle Chairman Larry Ellison discussed the potential of artificial intelligence (AI) to revolutionize healthcare.
Investing8h
Moderna stock jumps on AI healthcare prospects
Investing.com -- Moderna , Inc. (NASDAQ: MRNA) shares surged 14% following remarks by Oracle (NYSE: ORCL) Chairman Larry ...
Hosted on MSN4h
Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines
Moderna stock surged Wednesday after Oracle Chairman Larry Ellison praised the potential of AI in developing medicines.
S&P 500 Gains and Losses Today: Netflix Soars as Streamer Touts Subscriber Growth
Key Takeaways The S&P 500 advanced 0.6% on Wednesday, Jan. 22, 2025, following the announcement of major AI investments and a ...
HealthDay on MSN9h
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
This funding, announced Friday by Moderna, builds on the $176 million it received from HHS last year to support earlier stages of vaccine research.
Healthcare Finance News7h
HHS provides $590 million to Moderna amid vaccine controversy
A hearing on RFK Jr.'s appointment as HHS secretary has stalled; physicians protest his appointment and Trump has paused communications.
Republic-Times1h
Wagner offers health updates
Not long after the Illinois Department of Health announced the state’s overall respiratory illness cases had reached the ...